| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8830406 | Urology Practice | 2017 | 7 Pages |
Abstract
In the case of degarelix and denosumab there is a weak association between pharmaceutical company payments and prescriber prescription behavior patterns.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Jathin Bandari, Robert M. II, Bruce L. Jacobs, David Canes, Ali Moinzadeh, Benjamin J. Davies,